Thieler Law Corp advises investors with losses exceeding $100,000 of the April 27, 2020 lead plaintiff deadline in a class action lawsuit filed against Becton, Dickinson and Company (NYSE: BDX) (“Becton” or “the Company”). The suit is pending in the U.S. District Court for the District of New Jersey and investors, who purchased Becton, Dickinson and Company securities between November 5, 2019 and February 5, 2020, have until April 27, 2020 to move for lead plaintiff. You do not need to move for lead plaintiff to be a member of the Class.

If you purchased Becton, Dickinson and Company securities during the Class Period, and have losses over $100,000, you may contact Thieler Law Corp by calling at (619) 377 - 4324 or emailing mail@thielerlaw.com . No class has been certified in this case, and if your losses are less than $100,000 you are still a member of the class.

The complaint alleges that during the Class Period defendants made false and misleading statements and/or allegedly failed to disclose that certain of Becton’s Alaris infusion pumps experienced software errors and alarm prioritization issues; as a result, the Company was investing in remediation efforts to address these product issues, rather than a software upgrade to “make enhancements;” the Company was reasonably likely to face regulatory delays in connection with the software remediation; as a result of the foregoing, Becton was reasonably likely to recall certain of its Alaris infusion pumps; and as a result of the foregoing, the defendants’ public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

On February 6, 2020, the Company lowered its fiscal 2020 guidance, announcing that the Company expected revenue to increase by only 1.5% to 2.5%, "to reflect the impact of the remediation effort and anticipated loss of sales of the Alaris infusion system." According to Becton, the software remediation plan for the Company's Alaris system "will require additional regulatory filings," and existing customers would have "access to the Alaris System under medical necessity." Furthermore, the Company disclosed that it had recorded a $59 million charge in connection with a voluntary recall of certain Alaris pumps.

Following this news, Becton's stock price fell $33.74 per share, or 11.8%, to close at $252.25 per share on February 6, 2020.

If you were negatively impacted by your investment in Becton, Dickinson and Company  securities between November 5, 2019 and February 5, 2020 and would like to learn more about this lawsuit and your ability to participate as a lead plaintiff, please contact us for your no-cost evaluation.

Thieler Law Corp purchases advertisements on search engines, social media sites and other websites. If you send us information, note that does not create an attorney-client relationship with the firm. Materials are provided for informational purposes only and do not constitute legal advice. We are only licensed to practice law in Germany. We are neither licensed nor qualified to render advice on US Federal or State law.

Thieler Law Corp

2534 State Street - Suite 406,

San Diego, CA 92101

by

email: mail@thielerlaw.com

or

telephone at +1 (619) 377 - 4324

or

visit our website http://www.thielerlaw.com/

or

Facsimile: +1 (619) 785 – 3185